400 Participants Needed

E-Health Intervention for Type 2 Diabetes

(LUNA-E Trial)

PM
Overseen ByProgram Manager
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: San Diego State University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests a new e-health program aimed at improving blood sugar control and reducing stress, anxiety, and depression in people with Type 2 diabetes. It compares two groups: one receiving usual care with extra support from a care coordinator, and another with added digital tools and education specifically for Latino patients. The trial is ideal for Hispanic or Latino individuals diagnosed with Type 2 diabetes who have struggled to manage their blood sugar levels (HbA1c over 7.5%) in the past three months. As an unphased trial, this study provides a unique opportunity to contribute to innovative research tailored to the community's needs.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your primary care provider.

What prior data suggests that this E-Health intervention is safe for improving glycemic control and psychological distress in Latinos with Type 2 Diabetes?

Studies have shown that the LUNA Group's approach is generally safe for participants, focusing on managing healthcare and mental well-being. Participants receive assistance with scheduling appointments and taking medications, and they gain a better understanding of their health.

For the LUNA Behavioral Health component, research indicates that the program is culturally sensitive and well-liked. Although specific safety details are not provided, similar programs are typically safe and well-accepted.

LUNA Care Coordination also offers help with health education and appointments. Research has not identified any major safety concerns with this type of care.

Overall, these treatments emphasize support and education, which are generally low-risk and well-tolerated. Participants can expect a supportive environment aimed at improving their health.12345

Why are researchers excited about this trial?

Researchers are excited about these innovative approaches to managing Type 2 diabetes because they integrate modern technology and personalized care into treatment. The LUNA Behavioral Health approach stands out by using an E-Health enhanced, patient-centered model that includes real-time care coordination, specialized behavioral health support, and interactive self-management education delivered through a video-based learning system. This method is distinct from traditional treatments, which often rely solely on medication and periodic doctor visits, by actively engaging patients in their health management using digital tools and tailored education. Meanwhile, the LUNA Care Coordination arm builds on current care models by enhancing the role of care coordinators who assist patients with health education, appointment scheduling, and medication management, ensuring a seamless and supportive healthcare experience. These approaches aim to empower patients and potentially improve health outcomes by making care more accessible, personalized, and proactive.

What evidence suggests that this trial's treatments could be effective for Type 2 Diabetes?

Research has shown that the LUNA Group, a culturally tailored online health program, holds promise for improving diabetes care among Latinos. In this trial, participants in the LUNA Group will receive a combination of care coordination and mental health support. Studies suggest this approach can better manage blood sugar levels and reduce feelings of depression and anxiety. Participants in the Care Coordination arm will receive help with appointments, referrals, and medication management, which has improved emotional well-being. Overall, these programs use technology and personalized care to support better diabetes management.12467

Who Is on the Research Team?

GA

Gregory A Talavera, MD/MPH

Principal Investigator

San Diego State University

LC

Linda C Gallo, PHD

Principal Investigator

San Diego State University

Are You a Good Fit for This Trial?

This trial is for Hispanic/Latino adults with Type 2 diabetes and poor blood sugar control (HbA1c >8%). Participants must be registered at a qualifying health center, not in other diabetes programs, and have their doctor's approval. Exclusions include severe diabetes complications, current cancer or Parkinson's treatment, plans to move soon, severe health issues preventing consent, or being pregnant/nursing.

Inclusion Criteria

Registered patient of federally qualified health center
Self identify as Hispanic/Latino ethnicity of any race
Approval from primary care provider
See 2 more

Exclusion Criteria

Pregnant or nursing (temporary exclusion, may qualify 6-months postpartum)
Have other existing mental or physical health problems so severe as to prohibit informed consent and participation
You are planning to move away from the area within the next year.
See 2 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive a patient-centered, team-based, primary care intervention with E-Health enhancements to improve glycemic control and psychological distress

6 months
Visits at baseline, 3 months, 6 months, and 12 months

Follow-up

Participants are monitored for safety and effectiveness after treatment

6 months

What Are the Treatments Tested in This Trial?

Interventions

  • Health Education Videos
  • LUNA Behavioral Health
  • LUNA Care Coordination
  • Virtual Integrated Visits
Trial Overview The LUNA-E study is testing a patient-centered care approach using virtual visits, coordinated care management, integrated medical and behavioral support alongside educational videos. This randomized trial aims to improve blood sugar levels and reduce psychological distress among participants.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: LUNA GroupExperimental Treatment4 Interventions
Group II: Care CoordinationActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

San Diego State University

Lead Sponsor

Trials
182
Recruited
119,000+

Published Research Related to This Trial

A culturally tailored, integrated care intervention for low-income, Spanish-speaking Latinos with type 2 diabetes significantly improved HbA1c levels over 6 months, showing a greater reduction compared to usual care (ΔHbA1c = -0.35 vs. ΔHbA1c = -0.02).
The intervention also led to improvements in total cholesterol and diastolic blood pressure, indicating that this model of care can effectively support diabetes management and self-care in this population.
Latinos understanding the need for adherence in diabetes (LUNA-D): a randomized controlled trial of an integrated team-based care intervention among Latinos with diabetes.Talavera, GA., Castañeda, SF., Mendoza, PM., et al.[2022]
Latinos experience higher rates of diabetes and related complications, and existing health information technology (HIT) tools for diabetes management may not be effectively utilized by this group, especially those with low literacy or limited English proficiency.
The development of a novel 'eNavigator' role aims to enhance the adoption of HIT among Latinos, which could help improve diabetes self-management and reduce health care disparities.
Closing the gap: eliminating health care disparities among Latinos with diabetes using health information technology tools and patient navigators.López, L., Grant, RW.[2022]
The Innovative Care for Chronic Conditions framework was developed to improve chronic care management specifically for low-income, uninsured Mexican Americans with Type 2 diabetes, highlighting the importance of addressing health disparities.
Community health workers are crucial in delivering services that tackle social determinants of health, leading to promising outcomes and suggesting that this framework can be replicated in various settings to enhance chronic care management.
A Chronic Care Management Framework Bridging Clinic, Home, and Community Care in a Mexican American Population.Zolezzi, M., Lopez, J., Mitchell-Bennet, L., et al.[2022]

Citations

Latinos understanding the need for adherence in diabetes ...Hispanics/Latinos (hereafter Latinos) are disproportionately at-risk for type 2 diabetes [1] and have poor diabetes medication adherence [2], ...
Latinos Understanding the Need for Adherence in ...The LUNA Group is a culturally appropriate, E-Health enhanced, patient-centered, team-care model that includes: 1) care coordination by a Care Coordinator (CC) ...
Latinos Understanding the Need for Adherence in Diabetes ...If shown effective, LUNA-E has high potential for broad scaling and dissemination due to its community partnered approach, use of technology, ...
Latinos Understanding the Need for Adherence in ...... Behavioral Care and E-Health (LUNA-E) is a randomized controlled trial (RCT) that will test the effectiveness a patient-centered, team-based ...
Latinos Understanding the Need for Adherence in DiabetesThe study aims are to: 1) improve glycemic control, 2) improve cardiovascular risk profiles, 3) decrease psychological distress, and 4) evaluate the patient and ...
Latinos Understanding the Need for Adherence in ...LUNA-E will help advance our understanding of optimal approaches to diabetes healthcare services in a large, growing, US population at high ...
Latinos understanding the need for adherence in diabetes ...Latinos understanding the need for adherence in diabetes (LUNA-D): a randomized controlled trial of an integrated team-based care intervention among Latinos ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security